NCT02407405 2026-03-05
MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
University Health Network, Toronto
University of Birmingham
AstraZeneca
UNICANCER